Carboxy-terminal truncated STAT5 is induced by interleukin-2 and GM-CSF in human neutrophils

被引:13
作者
Epling-Burnette, PK
Garcia, R
Bai, FQ
Ismail, S
Loughran, TP
Djeu, JY
Jove, R
Wei, S
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Program, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, Interdisciplinary Oncol Program, Tampa, FL 33620 USA
[3] James A Haley Vet Adm Hosp, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Program Immunol, Tampa, FL 33612 USA
关键词
neutrophils; cytokines; signal transduction; STAT;
D O I
10.1016/S0008-8749(02)00522-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
IL-2 and GM-CSF are potent activators of polymorphonuclear neutrophils (PMN) biologic activity. IL-2 and GM-CSF-mediated activation of STAT proteins was examined in nuclear extracts of human PMN. We found that both cytokines induced STAT5-like DNA-binding complexes that could not be supershifted using C-terminal-specific anti-STAT5 antibodies. Therefore, we performed oligoprecipitation experiments with a STAT5-biotinylated DNA probe (biotin-MGFe) and the precipitated proteins were identified by Western inummoblotting. We found that GM-CSF and IL-2 induced the DNA-binding activity of a C-terminal truncated isoform of STAT5. The truncated STAT5 form was present in the nucleus of PMN but the cytoplasmic extracts contained full-length STAT5, suggesting that PMN proteolytically process full-length STAT5 proteins. Proteolytic experiments demonstrated that PMN express a protease activity capable of producing C-terminal processed STAT5 proteins. In many settings, C-terminal truncation of the STAT5 protein leads to inhibition of STAT5 biological activity. Two known STAT5 regulated genes, encoding pim-1 and OSM proteins, failed to be induced by GM-CSF in PMN. These findings provide new insights to a mechanism by which PMN, a terminally differentiated cell, may regulate gene transcription by alternative proteolytic processing. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 65 条
[1]   BCR-ABL fails to inhibit apoptosis in U937 myelomonocytic cells expressing a carboxyl-terminal truncated Stat5 [J].
Ahmed, M ;
Dusanter-Fourt, I ;
Dugray, A ;
Dubrez, L ;
Novault, S ;
Bonnet, ML ;
Gisselbrecht, S ;
Varet, B ;
Solary, E ;
Vainchenker, W ;
Turhan, AG .
LEUKEMIA & LYMPHOMA, 2001, 42 (03) :445-455
[2]   Functionally distinct isoforms of STAT5 are generated by protein processing [J].
Azam, M ;
Lee, C ;
Strehlow, I ;
Schindler, C .
IMMUNITY, 1997, 6 (06) :691-701
[3]   INTERLEUKIN-3 SIGNALS THROUGH MULTIPLE ISOFORMS OF STAT5 [J].
AZAM, M ;
ERDJUMENTBROMAGE, H ;
KREIDER, BL ;
XIA, M ;
QUELLE, F ;
BASU, R ;
SARIS, C ;
TEMPST, P ;
IHLE, JN ;
SCHINDLER, C .
EMBO JOURNAL, 1995, 14 (07) :1402-1411
[4]  
BLANCHARD DK, 1991, BLOOD, V77, P2259
[5]   Positive selection of apoptosis-resistant cells correlates with activation of dominant-negative STAT5 [J].
Bovolenta, C ;
Testolin, L ;
Benussi, L ;
Lievens, PMJ ;
Liboi, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (33) :20779-20784
[6]  
Brizzi MF, 1996, J BIOL CHEM, V271, P3562
[7]   PROTEIN-TYROSINE KINASE-DEPENDENT ACTIVATION OF STAT TRANSCRIPTION FACTORS IN INTERLEUKIN-2-STIMULATED OR INTERLEUKIN-4-STIMULATED T-LYMPHOCYTES [J].
BRUNN, GJ ;
FALLS, EL ;
NILSON, AE ;
ABRAHAM, RT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (19) :11628-11635
[8]   STAT3 beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription [J].
Caldenhoven, E ;
vanDijk, TB ;
Solari, R ;
Armstrong, J ;
Raaijmakers, JAM ;
Lammers, JWJ ;
Koenderman, L ;
deGroot, RP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :13221-13227
[9]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[10]   Stat3 and G-CSF-induced myeloid differentiation [J].
Chakraborty, A ;
Tweardy, DJ .
LEUKEMIA & LYMPHOMA, 1998, 30 (5-6) :433-+